Skip to main content
Caplight Logo









Stimunity

Stimunity

Private
ParisHealthcare & Life Scienceshttps://stimunity.com

Last Round

Seed

May 11, 2020

Total Funding Raised

$4.46M

Company Overview

Stimunity operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Seed round in May 2020.

Stimunity is a biotechnology company that develops drugs on the STING pathway to activate the innate immune system to fight cancer and infectious pathogens.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Stimunity Comparables

Compare Stimunity with similar companies based on industry and business-model similarity.

Stimunity comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Saros Therapeutics
83%
Portage Biotech Inc
81%
ImmuneSensor Therapeutics
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Stimunity Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 11, 2020
GrantOct 21, 2019
GrantMar 25, 2019
SeedMar 25, 2019
SeedFeb 28, 2018
Grant
Jul 10, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Stimunity Investors

Notable investors and investment history

Stimunity investors
InvestorRounds
Région Île-de-FranceGrant
European CommissionGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Monthly visitors grew 345% MoM, from 248 to 1.1K.

  • May 11, 2020

    $990K round led by Portage Biotech Inc

Book a demo to see all signals

For institutional investors. Book with your work email.

Stimunity Filings

Explore SEC and related filing metadata, where available.

Stimunity filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Stimunity's valuation, stock price, and market status.

Is Stimunity a public or private company?

Stimunity is a private company.

What is the current stock price of Stimunity?

Stimunity is a private company, so its shares have no public market price. Caplight tracks Stimunity's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Stimunity worth (valuation)?

Valuation information for Stimunity is not publicly available.

Can I buy Stimunity stock?

Stimunity shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Stimunity's last funding round?

Stimunity's most recent funding round was Seed on May 11, 2020.

Who are the main investors in Stimunity?

Key investors in Stimunity include Région Île-de-France, European Commission.

Will Stimunity IPO soon?

No public IPO plans have been announced for Stimunity.

How can I track Stimunity secondary market activity?

Caplight tracks bids, offers, and trades in Stimunity's shares on secondary markets.

Firmographic Details

HeadquartersParis
Employee Range2
Year Founded2016
Last FundingMay 11, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?